Introduction {#sec1}
============

Meningitis is an infection of the membranes and cerebrospinal fluid (CSF) surrounding the brain and spinal cord. It is a severe disease of serious public health importance that is responsible for substantial morbidity and mortality and may be caused by infection with a large variety of bacteria, viruses, fungi, or parasites \[[@cit0001]\]. Bacterial meningitis requires prompt recognition and treatment \[[@cit0002]\]. Accurate and timely identification of the etiological agents that cause bacterial meningitis and the populations at risk of bacterial meningitis is important to initiate public health measures and ensure appropriate management \[[@cit0003]\].

The epidemiology of bacterial meningitis varies by country and depends on factors such as the availability and use of vaccines against various etiologies and other risk factors associated with immune status of individuals who become infected. In the Middle East, *N. meningitides* (30%), *H. influenza* (20%) and *S. pneumonia* (50%) have been reported as the predominant pathogens \[[@cit0004], [@cit0005]\]. The most common agents in adults and children are *S. pneumonia* and *N. meningitides*, because vaccination has virtually eliminated *H. influenza* type b (Hib) meningitis in children where Hib vaccine is given \[[@cit0006], [@cit0007]\]. Studies among children and adults have identified factors associated with bacterial meningitis infection including being younger than one year of age due to a naive/immature immune system, waning of protective maternal antibody levels and exposure to young adult carriers in the household \[[@cit0008]\]. Close and prolonged contact with a carrier, household crowding, travelling to countries with epidemic area are also risk factors for infection. Alcoholism, human immunodeficiency virus (HIV) infection, diabetes mellitus, the use of immunosuppressive drugs and cancer may cause dysfunction of the immune system and thereby increase the risk of invasive infections, including meningitis \[[@cit0009]\].

In developing countries, *S. pneumonia* has been identified as a leading cause of meningitis among children and adults \[[@cit0010]-[@cit0012]\]. In Kenya, a study conducted in 2015 among HIV-infected Kenyan patients in the year before pneumococcal conjugate vaccine (PCV) introduction showed 43% of them were infected with Streptococcus pneumonia \[[@cit0011]\]. Further studies evaluating etiology and correlates of bacterial meningitis in Kenya are vital for case management. Accurate laboratory identification of the etiology of bacterial meningitis is essential to provide optimal patient therapy, appropriate case management, effective public health actions and information upon which to base decisions regarding immunization programs \[[@cit0002], [@cit0003]\]. We investigated three important etiologies of bacterial meningitis (*S. pneumonia*, N. Meningitidis, and *H. influenza*e) among patients with meningitis-like symptoms admitted at Mama Lucy Kibaki Hospital, a county hospital serving a large population of low-income earners, inhabitants of Nairobi, Kenya.

Methods {#sec2}
=======

Study design, setting and case definition {#sec2.1}
-----------------------------------------

This pilot surveillance program for bacterial meningitis was carried out at Mama Lucy Hospital, in Nairobi the most populated, capital city of Kenya. The hospital serves mainly low-income community members. On a monthly basis, the hospital provides care for \~ 28,000 outpatients, \~ 1,200 inpatients and \~ 750 deliveries at a minimum every month. Patients of all ages presenting with meningitis-like symptoms including fever, severe and persistent headache, neck stiffness, seizures were identified as suspected cases of meningitis.These patients were requested to provide informed consent or assent if minors and asked if they were available for a 20-minute interview.

Sampling strategy {#sec2.2}
-----------------

Because there were not sufficient resources for laboratory testing of all suspected cases of bacterial meningitis, a systemic sampling method was used to select patients for enrollment. We created a sampling frame using the laboratory register, which contained 438 entries of patients that met the case definition, as obtained from the nursing desk which included the period of January to December 2015 ([Figure 1](#f0001){ref-type="fig"}). Between 20 and 25 samples were collected per month between the months of May to December 2015.

![flow chart of participant's recruitment, data collection and spatial analysis](PAMJ-SUPP-28-1-10-g001){#f0001}

Data collection {#sec2.3}
---------------

Interviews and health record review {#sec2.4}
-----------------------------------

Patients enrolled by the resident doctor had their medical files reviewed to obtain information on: HIV status, medical history, vaccination history and meningitis signs and symptoms. Symptoms of meningitis included: fever, severe persistent headache, neck stiffness, nausea and vomiting, confusion and disorientation, drowsiness or sluggishness, sensitivity to bright light, poor appetite and more severe symptoms including seizure and coma. When able to respond, adult patients or guardians of minor patients were interviewed using structured questionnaires to gather information such as: demographic characteristics, healthcare access, onset of ailment, contact and possible mode of infection, social support and confirmation of vaccination history when the reports were missing from the charts.

Laboratory test {#sec2.5}
---------------

The lumbar puncture technique was used to collect cerebrospinal fluid (CSF) into three tubes for chemistry, microbiology and cytology which is a standard procedure done for all patients with suspected meningitis at the hospital. CSF specimens were transported to the National Microbiology Reference Laboratory located at National Public Health Laboratory Services complex within thirty minutes of collection. Two ml of CSF were dispensed into cryotubes and stored at -80°C until further testing. The methods described by Berkley et al., 2001 \[[@cit0013]\] were used to analyze the CSF. The sample was centrifuged for 10-15 minutes at 1000 rpm, 1-2 drops of the well-mixed CSF sediment were placed on the slide and air dried. The smears were fixed using 95% methanol, stained using the standard method and examined with 100X oil immersion objective. CSF specimens were cultured using standard techniques described by Berkley et al., 2005 \[[@cit0014]\]. About 20μl of CSF were inoculated onto plates of 7% sheep-blood agar and 5% chocolate blood agar and incubated at 36.5°C for 18-24h in a candle jar.

Plates without visible signs of growth were incubated for additional 24 hours. The bacterial identification was done using the guidelines described by Garcia et al. \[[@cit0015]\]. The bacterial DNA were extracted from the last portion of CSF samples using QIAGEN DNA extraction kit (Hilden, Germany) according to the kit manufacturer's instructions. Amplification was done using semi-nested multiplex PCR using universal primers for the bacterial 16s rDNA, and specific primers for *S. pneumonia* (STREP), *H. influenza* (HI) and *N. meningitides* (NM), in a 25μl reaction volume the amplification condition (using AB 9700 Thermocylcer, USA) as follows: 5 minutes initial denaturation at 94°C, 35 cycles of denaturation for 30 seconds at 94°C, annealing for 30 seconds at 55°C and extension for 30 seconds at 72°C, and a final extension incubation for 15 minutes at 72°C. Detection was done using ethidium bromide stained 1.5% agarose gel electrophoresis under ultraviolet rays at 300 nm in an HP AlphaImager® (Alpha Immutech/South Africa). The PCR primers did not differentiate the serotypes of the bacteria.

Data management and analysis {#sec2.6}
----------------------------

Prior to any protocol-related procedures being conducted, patients were assigned unique identification numbers (UIN) to allow linkage between information from questionnaires and biological specimens. All patient's information was entered into the study databases (Microsoft excel and STATA files) associated with a UIN in password protected files. Double entry systems for the data were maintained. The questionnaires records were kept in a locked filing cabinet located in a restricted-access room at the research station. Frequency and percentages were calculated for characteristics such as age, gender, occupation, underlying conditions of patients with laboratory confirmed bacterial meningitis infection. All statistical analyses were performed using STATA version 13 (StataCorp LP, Texas, USA). Crowding was defined as more than five people in a one to two roomed house while spatially crowded was defined as less than 3 people in one to two roomed house. An infant was defined as ages 1 to 28 days, a child was defined as one month to 18 years of age and an adult was a patient age greater than 18 years.

Ethical consent and approvals {#sec2.7}
-----------------------------

Consent was obtained from the patients or guardian for the minors by the research nurse. Approval to conduct the study was granted by the hospital medical super intendent before commencement of recruitment exercise. This study was reviewed and approved by the Jaramogi Oginga Odinga Teaching and Referral Hospital-Ethics & Research Committee (ERC.IB/VOL.1/167).

Results {#sec3}
=======

During recruitment of participants, 318 were selected, 248 were eligible and 196 were enrolled for the study ([Figure 1](#f0001){ref-type="fig"}). All the 196 participants or their guardians, where applicable, consented to participate in the study and CSF was collected ([Table 1](#t0001){ref-type="table"}). Patients were 55% male. The median age of the participants was one year (range, 1 to 37 years). About 53% of participants resided in urban informal settlements. The median household size was 4 persons (range, 4 to 7 persons). There were 99% participants with fever, 70.4% with stiff neck, 75% were irritable, 68.9% were drowsy, 90.8% were vomiting; 3.1% of the participants were identified as HIV positive. Using PCR, 22 out of 196 (11%) samples had evidence of a bacterial infection. These included 12 of 22 (55%) *S. pneumonia*, 7 of 22 (32%) *N. meningitides* and 3 of 22 (14%) *H. influenza*. The three pathogens shared similar seasonality being identified between the months of June to November. Of the seven samples positive for *N. meningitides*, five were from female patients. All seven of the patients with *N. meningitides* by PCR were aged between 1 to 4 years ([Table 1](#t0001){ref-type="table"}). None of the patients had received meningococcal vaccine. Four of those with positive *S. pneumonia* using culture were also positive by PCR. Seven patients with evidence of *S. pneumonia* had received at least one dose of Pneumococcal Conjugated Vaccine (PCV10) while 5 were completely unvaccinated.

###### 

distribution in the etiology of bacterial meningitis across patients' characteristics

  Variable              Sample size (N = 196)   Type of Bacteria identified                       
  --------------------- ----------------------- ----------------------------- --------- --------- ----------
  **Gender**                                                                                      
  Male                  107 (54.6)              97 (49.5)                     3 (1.5)   2 (1.1)   5 (2.6)
  Female                89 (45.4)               77 (32.3)                     0         5 (2.6)   7 (3.6)
  **Age**                                                                                         
  Infant                144 (73.5)              126 (64.3)                    2 (1.1)   5 (2.6)   11 (5.6)
  Children              23 (11.7)               19 (9.7)                      1 (0.5)   2 (1.1)   1 (0.5)
  Adult                 7 (3.6)                 7 (3.6)                       0         0         0
  **Region**                                                                                      
  Crowded               104 (53.1)              89 (45.4)                     2 (1.1)   4 (2.1)   9 (4.6)
  Spatially crowded     92(46.9)                85(43.4)                      1(0.5)    3 (1.5)   3 (1.5)
  **Household size**                                                                              
  ≤4                    129 (65.8)              117 (59.7)                    1 (0.5)   3 (1.5)   8 (4.1)
  ≥5                    67 (34.2)               57 (29.1)                     2 (1.1)   4 (2.1)   4 (2.1)
  **Household rooms**                                                                             
  1-2                   139 (70.9)              125 (63.8)                    2 (1.1)   5 (2.6)   7 (3.6)
  \>3                   57 (29.1)               49 (25)                       1 (0.5)   2 (1.1)   5 (2.6)
  **Pneumonia**                                                                                   
  Yes                   51 (26.1)               42 (21.4)                     2 (1.1)   4 (2.1)   3 (1.5)
  No                    145 (73.9)              132 (67.3)                    1 (0.5)   3 (1.5)   9 (4.6)

From bacterial culture, four of 196 (2.1%) CSF specimens grew *S. pneumonia*. Out of 12 samples found positive for *S. pneumonia*, eleven were from patients aged between 1 to 4 years and seven were detected from female patients. One participant with *S. pneumonia* infection had diabetes ([Table 1](#t0001){ref-type="table"}). Household size and household crowding characteristics are given in [Table 1](#t0001){ref-type="table"}. All three specimens positive for *H. influenza* were from male patients, among whom 2 were 1 year and 1 was 4 years old and one of these patients with *H. influenza* were HIV infected. Two out of three *H. influenza* positive specimens came from patients who had pneumonia ([Table 1](#t0001){ref-type="table"}). The two 1-year-old patients with *H. influenza* had not been vaccinated against Haemophilus influenza type b (Hib).

Discussion {#sec4}
==========

The findings are consistent with other findings: that young and unvaccinated children (aged 1 to 4 years) often present with bacterial meningitis because of their immunologically vulnerable state \[[@cit0016]\]. This study detected the three important bacteria etiologies in 11% cases of suspected bacterial meningitis cases. Various prevalence rates of bacterial meningitis have been reported elsewhere in Kenya, which may relate to different study designs, as well as changes in epidemiology and prevention efforts, including vaccination programs. In Kilifi, Kenya, a 2011 study reported a 6% prevalence of bacterial meningitis in all hospital admissions \[[@cit0017]\] with the most common bacterial etiologies *S. pneumonia*, Group B Streptococcus and *H. influenza* \[[@cit0017]\]. In Western Kenya a study found *S. pneumonia* at a prevalence of 38.6 % was the leading cause of meningitis among infants aged \< 60 days in 2011 \[[@cit0017]\]. In 2013 the largest tertiary hospital in Nairobi, Kenya \[[@cit0018]\] reported 20% of confirmed cases of bacterial meningitis were caused by *S. pneumonia*.

This study did not identify other possible etiologies of our meningitis cases that include other bacterial organisms such as Sphingobacterium multivorum \[[@cit0019]\], Tuberculous meningitis \[[@cit0020]\], Aeromonas hydrophila \[[@cit0021]\], or fungal species (Candida albicans, Cryptococcus sps) \[[@cit0022]\], or viral etiologies including enteroviruses, mumps virus, herpes viruses, influenza viruses, cytomegalovirus (CMV) and Epstein-Barr Virus (EBV). Enteroviruses are responsible for about 90% of aseptic meningitis worldwide, especially in underdeveloped countries with poor sanitation and low standards of hygiene \[[@cit0023], [@cit0024]\].

Our study reported *S. pneumonia* as the most common etiology, followed by *N. meningitides* and *H. influenza* as a causative agent of bacterial meningitis, the study did not include the serotypes of the pathogens. Similar reports of bacterial infection in neonates and young infants in 2010 and 2011 showed the predominance of *S. pneumonia* as the most common etiology of bacterial meningitis have been documented in other regions of Kenya \[[@cit0017], [@cit0025]\]. In the "meningitis belt" of Sub-Saharan Africa, comprising of 26 countries from Senegal in the west to Ethiopia in the east before 2010, *N. meningitides* was responsible for the large majority of bacterial meningitis epidemics \[[@cit0026]\]. The 2010 progressive introduction of a meningococcal A conjugate vaccine in the 26 countries in the African meningitis belt has brought about a dramatic reduction of *N. meningitides* with the relative proportion of cases due to *S. pneumonia* rising \[[@cit0027]\]. The meningococcal conjugate vaccine against group A was introduced in Africa in 2010 with some parts of Kenyan population (Coastal Kenya) who were vaccinated. However, none of the Study participant had received meningococcal vaccine. Pneumococcal conjugate vaccine (PCV) given as PVC10 was introduce in the Kenya vaccination program in 2011 and coverage is estimated at 54% by the Ministry of Health. Vaccine against H influenza type b was introduced in 2001 delivered in combination with diphtheria, tetanus, pertussis and hepatitis B as pentavalent (DTP-Hib-Hep) and is given in three doses to the children at the age of six, ten and fourteen weeks. DTP-Hib-Hep Coverage was estimated at 52% as at July 2017 by the Kenya expanded Programme of immunization but there was high dropout rate for children who did not finish all the three doses.

Differences in the epidemiology of bacterial meningitis relates to factors including geographical conditions and presence of vaccination programs for Meningococcal, *H. influenza* type B and *S. pneumonia* \[[@cit0028]\]. The current study occurred in only one site and therefore results are not necessarily generalizable to the whole country. The cases were isolated between the months of June to November, which is a relatively wet season in Kenya. Bacterial meningitis is more common during dry seasons, in rural areas and in crowded informal urban settlements \[[@cit0029]\]. One patient was diabetic with bacterial meningitis infection in this study Bacterial infection have been shown to contribute about 49% of the diabetic ketoacidosis cases \[[@cit0030], [@cit0031]\]. Diabetic ketoacidosis is a life-threatening acute complication of type 1 diabetes mellitus. The associations of diabetic ketoacidosis with tuberculous meningitis and group B streptococcal meningitis have been reported \[[@cit0030], [@cit0031]\].

Several limitations of the study are worth mentioning, first, although the focus of this study was to evaluate the etiology of meningitis, onset of symptoms and accompanying treatment strategies were not captured. This was a small study which may not be representative nationally for all of Kenya.

Conclusion {#sec5}
==========

Bacteria causing meningitis was isolated especially among younger and some unvaccinated (1 to 4 years) patients. This calls for the improvement and adoption of modern methods to diagnosis the etiological agents of meningitis in order to offer proper management meningitis especially in children given the documented difficulties in distinguishing bacterial meningitis clinically in this age group because of the no-specificity features of bacterial meningitis. Although our study did not serotype bacterial isolates, a number of cases were unvaccinated, therefore immunization against bacterial pathogens should be ensured.

What is known about this topic {#sec5.1}
------------------------------

-   *S. pneumonia*, *N. meningitides* and *H. influenza*e are the most common bacterial pathogens associated with bacterial meningitis;

-   Use of meningitis vaccine is a good prevention strategy of bacterial meningitis but it is not included in routine immunization schedule in the country.

What this study adds {#sec5.2}
--------------------

-   It is discovered in this study that *S. pneumonia* is the most common cause of bacterial meningitis in this sub-urban population.
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